Plantafood Medical starts 2026 with innovative strength and growth
New year, new investments, newperspectives
Laudert, January 2026 – At the start of the new year, Plantafood Medical GmbH wishes all its customers, partners, and employees a healthy, successful, and collaborative 2026. With great confidence and clear growth targets, the company is embarking on a new chapter that will be characterized by innovation, capacity expansion, and consistent customer focus.
As a specialized contract manufacturer of dietary supplements and feed supplements, Plantafood Medical is looking ahead with optimism. A key milestone at the beginning of the year is the targeted investment in modern technology. With this investment, the company is looking ahead to additional capacity and creating ideal conditions for further growth, the highest quality, and maximum delivery reliability.
At the same time, organizational expansion is also being driven forward: the sales team is growing. With another experienced sales employee — Andreas Köhler, who joined the team at the beginning of the year — Plantafood Medical is specifically strengthening personal customer service and the expansion of sustainable partnerships.
A particular highlight in 2026 will be Plantafood Medical's continued presence at Vitafoods Europe in Barcelona– this time with its own exhibition stand. As one of the world's leading trade fairs for nutraceuticals, Vitafoods offers the ideal platform for personal exchanges, new contacts, and the strengthening of existing partnerships.
“2026 will be a year of expansion and further development for us. We are consciously investing in technology, people, and structures so that we can continue to be a reliable and innovative partner for our customers in the future.”
– Christian, Managing Director of Plantafood Medical.
With a strong team, a clear strategy, and many new projects, Plantafood Medical is looking forward to the new year with optimism and is excited about continuing to grow together with its customers, partners, and employees.